Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bin Xiao"'
Autor:
Shuxin Shen, Yun-bin Xiao, Zonglei Zhao, Hairui Li, Feng Liu, Jianping Bin, Yan Wang, Ye Yuan, Chuanxi Zhang, Nvqin He, Ying Li, Shengcun Guo, Wangjun Liao, Yulin Liao, Junfen Wang, Yanmei Chen, Yongkang Lu
Publikováno v:
Biomaterials. 181:293-306
With the rapid development of cancer-targeted nanotechnology, a variety of nanoparticle-based drug delivery systems have clinically been employed in cancer therapy. However, multidrug resistance significantly impacts the therapeutic efficacy. Physica
Autor:
Youping Liu, Jinju Wang, Ying Cheng, Run Chen, Chunyan Duan, Chunhong Feng, Rongyang Dai, Bin Xiao, Hong Li, Fuli Yao, Hong Zhou, Jing Li, Chunyan Zhang, Xiaofang Zhao
Publikováno v:
Oncotarget
// Xiaofang Zhao 1, * , Chunyan Zhang 1, * , Hong Zhou 1, * , Bin Xiao 1 , Ying Cheng 1 , Jinju Wang 2 , Fuli Yao 1 , Chunyan Duan 1 , Run Chen 3 , Youping Liu 2 , Chunhong Feng 2 , Hong Li 1 , Jing Li 2 , Rongyang Dai 1 1 Department of Biochemistry
Autor:
Yongyin He, Jingrun Lu, Jing Qu, Weiwei Li, Jianfeng Hang, Wenbo Hao, Zhenzhan Kuang, Zhaohui Sun, Ting Lei, Chun Deng, Weiyun Zhang, Bin Xiao, Linhai Li, Lidan Chen, Quan Zhou
Publikováno v:
Molecular Carcinogenesis
Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) is an important excitatory neurotransmitter receptor that plays a significant role in various neurodegenerative diseases. However, the biological functions of GRIK3 in malignancies are larg
Autor:
Hong Bin Xiao, Xiao Ni Liu, Ying Chen, Wei Yan Cai, Ya Jie Wang, Yan Guo, Xiao Gang Weng, Xi Chen, Yu Jie Li, Xiao Xin Zhu, He Fei Huang, Qi Li, Xiao Xi Kan, Qing Yang
Publikováno v:
Drug Design, Development and Therapy
Ya Jie Wang,1 Qi Li,1 Hong Bin Xiao,1 Yu Jie Li,1 Qing Yang,1 Xiao Xi Kan,1 Ying Chen,1 Xiao Ni Liu,2 Xiao Gang Weng,1 Xi Chen,1 Wei Yan Cai,1 Yan Guo,1 He Fei Huang,1 Xiao Xin Zhu11Institute of Chinese Materia Medica, China Academy of Chinese Medica
Publikováno v:
Chinese Journal of Cancer. 29:741-746
BACKGROUND AND OBJECTIVE Rosiglitazone is a peroxisome proliferators-activated receptor gamma (PPARgamma) ligand, which inhibits tumor growth by activating PPARgamma signaling pathways. Fluorouracil (5-FU) is one of the commonly used chemotherapeutic
Autor:
Christina L. Addison, James Villeneuve, Khalid N. Al-Zahrani, Grant A. Howe, Mohamed Shaad Hasim, Bin Xiao, Luc A. Sabourin, Glenwood D. Goss, Huijun Zhao, Harmanjatinder S. Sekhon, Jim Dimitroulakos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 3, p e0150567 (2016)
PLoS ONE, Vol 11, Iss 3, p e0150567 (2016)
Blockade of epidermal growth factor receptor (EGFR) activity has been a primary therapeutic target for non-small cell lung cancers (NSCLC). As patients with wild-type EGFR have demonstrated only modest benefit from EGFR tyrosine kinase inhibitors (TK
Autor:
Jia-xin Min, Yin-bin Xiao, Pin Qian, Zubin Yu, Li Bai, Guisheng Qian, Guansong Wang, Chunxue Bai
Publikováno v:
Cell biology international. 33(9)
SOCS3 is regarded as a major negative regulator of STAT3. Recent evidence indicates that SOCS3 regulates strength and duration of other signaling pathways including ras/ERK1/2/MAPK, PI3-K/Akt in non-malignant cells. The repression or silence of SOCS3